Invivyd Inc

IVVD

Company Profile

  • Business description

    Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

  • Contact

    1601 Trapelo Road
    Suite 178
    WalthamMA02451
    USA

    T: +1 781 819-0080

    https://www.invivyd.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    100

Stocks News & Analysis

stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks

Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27

Charts from the Australian Dividend Outlook show the sectors where they are abundant.
stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,276.6019.90-0.21%
CAC 408,041.3618.77-0.23%
DAX 4024,611.2514.120.06%
Dow JONES (US)46,310.61291.17-0.62%
FTSE 1009,509.4039.47-0.41%
HKSE26,752.5976.87-0.29%
NASDAQ22,940.17103.21-0.45%
Nikkei 22548,580.44845.451.77%
NZX 50 Index13,570.862.380.02%
S&P 5006,720.7632.96-0.49%
S&P/ASX 2008,969.8025.20-0.28%
SSE Composite Index3,933.9751.201.32%

Market Movers